Pharmacoeconomic considerations for allergen immunotherapy.
Bernstein
Jonathan A
JA
University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
D001249:Asthma / Q000175:diagnosis / Q000191:economics / Q000628:therapy; D003365:Costs and Cost Analysis / Q000191:economics; D003888:Desensitization, Immunologic / Q000191:economics*; D017850:Economics, Pharmaceutical; D018588:Fee-for-Service Plans / Q000191:economics; D006801:Humans; D018579:Patient Selection; D015995:Prevalence; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000191:economics / Q000628:therapy; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology